Aurobindo Pharma Share Price

Aurobindo Pharma Share Price

  • 1,453.604.60 (0.32%)
  • Closed
  • As On: 10 Jun, 2026, 03:50 PM IST
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Try ETMarkets GPTNEW
Open1,443.80
High1,468.40
Low1,437.10
Prev Close1,449.00
Volume11,23,785
VWAP(₹)1,451.21

Key Metrics

PE Ratio(x)22.62
EPS - TTM(₹)64.26
MCap(₹ Cr.)84,425.32
MCap Rank9
PB Ratio(x)2.22
Div Yield(%)0.28
Face Value(₹)1.00
52W High(₹)1,550.00
52W Low(₹)1,016.10
MCap/Sales2.25
Beta(1 Month)1.73
BV/Share(₹)652.25

Aurobindo Pharma share price insights

Rank 96 - ET 5002025 ranking

  • Intraday fact check

    In the last 21 years, only 2.58 % trading sessions saw intraday gains higher than 5 % .

  • Employee & Interest Expense

    Company has spent 1.14% of its operating revenues towards interest expenses and 15.42% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

  • Candle Formations Yesterday

    White Spinning Top was formed for Aurobindo Pharma

  • Aurobindo Pharma Share Price Update

    Aurobindo Pharma Ltd. share price moved up by 0.32% from its previous close of Rs 1,449.00. Aurobindo Pharma Ltd. stock last traded price is 1,453.60

    Share PriceValue
    Today/Current/Last1,453.60
    Previous Day1,449.00

Found Insights useful?

Aurobindo Pharma Share Price Returns

1 Day0.32%
1 Month-2.27%
3 Months13.04%
1 Year24.14%
3 Years117.15%
5 Years50.79%

Aurobindo Pharma Share Recommendations

Mean recosCurrent
BUY

27 Analysts

Strong
SellSellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy8899
Buy10101212
Hold551-
Sell3334
Strong Sell1111
# Analysts27272626
Recent Recos
  • Target₹1330
  • OrganizationICICI Securities
  • ADD
  • Target₹1755
  • OrganizationHDFC Securities
  • BUY
  • Target₹1500
  • OrganizationAxis Securities
  • OVERWEIGHT
View all Stock Recommendations

News & Analysis

View all Aurobindo Pharma Share News & Announcements

Financials

  • Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income8,833.548,406.297,973.448,516.938,135.81
    Total Income Growth (%)5.085.43-6.384.682.57
    Total Expenses7,402.627,036.796,670.817,034.636,819.07
    Total Expenses Growth (%)5.205.49-5.173.163.13
    EBIT1,430.921,369.501,302.631,482.301,316.74
    EBIT Growth (%)4.485.13-12.1212.57-0.24
    Profit after Tax (PAT)1,138.01848.45824.75903.47845.81
    PAT Growth (%)34.132.87-8.716.823.48
    EBIT Margin (%)16.2016.2916.3417.4016.18
    Net Profit Margin (%)12.8810.0910.3410.6110.40
    Basic EPS (₹)15.6714.6114.2015.5614.56
    Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income2,877.432,949.242,931.942,845.972,970.89
    Total Income Growth (%)-2.430.593.02-4.200.80
    Total Expenses2,047.102,136.512,121.852,229.362,271.76
    Total Expenses Growth (%)-4.180.69-4.82-1.874.60
    EBIT830.33812.73810.09616.61699.13
    EBIT Growth (%)2.170.3331.38-11.80-9.83
    Profit after Tax (PAT)582.07581.37559.13408.17472.05
    PAT Growth (%)0.123.9836.98-13.53-12.18
    EBIT Margin (%)28.8627.5627.6321.6723.53
    Net Profit Margin (%)20.2319.7119.0714.3415.89
    Basic EPS (₹)10.0210.019.637.038.13
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue32,345.5829,559.2525,145.9723,775.8425,155.47
    Total Revenue Growth (%)9.4317.555.76-5.488.01
    Total Expenses27,247.6024,970.2422,521.8020,243.8820,571.10
    Total Expenses Growth (%)9.1210.8711.25-1.595.46
    Profit after Tax (PAT)3,485.883,172.971,927.502,648.155,334.84
    PAT Growth (%)9.8664.62-27.21-50.3688.45
    Operating Profit Margin (%)17.5116.8211.1215.2618.80
    Net Profit Margin (%)10.9810.947.7511.2921.53
    Basic EPS (₹)59.8154.1632.9045.1991.05
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue11,261.4211,261.7013,226.0411,958.1316,413.54
    Total Revenue Growth (%)0.00-14.8510.60-27.1420.07
    Total Expenses8,902.978,858.7811,611.6910,245.9412,220.53
    Total Expenses Growth (%)0.50-23.7113.33-16.168.22
    Profit after Tax (PAT)1,746.791,954.141,230.411,454.713,112.91
    PAT Growth (%)-10.6158.82-15.42-53.2766.22
    Operating Profit Margin (%)23.6724.2813.5115.3126.67
    Net Profit Margin (%)15.9718.359.6112.8819.67
    Basic EPS (₹)29.9733.3521.0024.8353.13

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Employee & Interest Expense

      Company has spent 1.14% of its operating revenues towards interest expenses and 15.42% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets49,784.9745,071.5139,889.9933,921.7233,853.99
    Total Assets Growth (%)10.4612.9917.590.2017.04
    Total Liabilities17,138.0415,220.7113,038.149,347.6711,925.00
    Total Liabilities Growth (%)12.6016.7439.48-21.61-1.58
    Total Equity32,646.9329,850.8026,851.8524,574.0521,928.99
    Total Equity Growth (%)9.3711.179.2712.0630.45
    Current Ratio (x)1.851.981.872.221.86
    Total Debt to Equity (x)0.240.210.180.100.23
    Contingent Liabilities2,349.813,323.111,813.211,145.451,083.17
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets27,513.0625,153.9824,933.6521,600.9523,188.99
    Total Assets Growth (%)9.380.8815.43-6.8518.71
    Total Liabilities6,978.955,431.167,019.484,483.617,264.38
    Total Liabilities Growth (%)28.50-22.6356.56-38.2811.60
    Total Equity20,534.1119,722.8217,914.1717,117.3415,924.61
    Total Equity Growth (%)4.1110.104.667.4922.26
    Current Ratio (x)1.201.381.462.351.83
    Total Debt to Equity (x)0.230.140.230.110.25
    Contingent Liabilities1,329.982,053.57596.69277.611,337.36

    All figures in Rs Cr, unless mentioned otherwise

    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities3,924.622,434.522,386.755,016.483,328.92
    Net Cash used in Investing Activities-1,875.80-4,255.95-3,977.75-3,211.56598.69
    Net Cash flow from Financing Activities119.78800.421,814.41-2,969.27-1,364.81
    Net Cash Flow2,178.36-1,006.84229.76-1,167.402,583.09
    Closing Cash & Cash Equivalent5,563.793,385.434,392.274,162.515,329.91
    Closing Cash & Cash Equivalent Growth (%)64.35-22.925.52-21.9094.04
    Total Debt/ CFO (x)2.022.592.040.471.49
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities1,645.791,714.801,821.163,726.712,994.41
    Net Cash used in Investing Activities-2,065.90-159.96-3,459.68-1,613.51-2,648.73
    Net Cash flow from Financing Activities616.31-1,837.031,719.48-2,447.54-27.94
    Net Cash Flow211.94-273.8181.44-335.37316.23
    Closing Cash & Cash Equivalent295.2683.32129.6548.21383.58
    Closing Cash & Cash Equivalent Growth (%)254.37-35.73168.93-87.43545.32
    Total Debt/ CFO (x)2.811.642.270.491.32

    All figures in Rs Cr, unless mentioned otherwise

    Insights

    • Increase in Cash from Investing

      Company has used Rs 3458.43 cr for investing activities which is an YoY increase of 84.37%. (Source: Consolidated Financials)
    View Details
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)10.6710.637.1810.7724.32
    Return on Capital Employed (%)15.8214.849.7313.8920.09
    Return on Assets (%)7.007.034.837.8015.75
    Interest Coverage Ratio (x)15.7622.0928.5496.7776.71
    Asset Turnover Ratio (x)0.670.680.670.690.79
    Price to Earnings (x)19.3420.1215.7514.819.69
    Price to Book (x)2.062.141.131.592.36
    EV/EBITDA (x)9.319.987.277.948.95
    EBITDA Margin (%)22.7122.0616.1320.0623.06
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)8.509.906.868.4919.54
    Return on Capital Employed (%)12.2712.989.479.9225.69
    Return on Assets (%)6.347.764.936.7313.42
    Interest Coverage Ratio (x)12.5415.5518.83126.59164.22
    Asset Turnover Ratio (x)0.420.430.550.500.74
    Price to Earnings (x)38.6132.6824.6926.9516.61
    Price to Book (x)3.283.241.692.293.24
    EV/EBITDA (x)24.8423.4315.8719.1011.72
    EBITDA Margin (%)26.3926.6716.9218.9929.76

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

  • No Data Available

  • 44%
    Positive Movement
    since 1st Jan 2005
    on basis
    55%
    Negative Movement
    since 1st Jan 2005
    on basis
    Exclude

    Global Meltdown1st Jan 2008 to 10th Nov 2008

    Covid Crisis1st Feb 2020 to 31st Mar 2020

  • R11472.77Pivot

    1454.93

    		S11441.47
    R21486.23S21423.63
    R31517.53S31392.33
  • 5 Days14 Days28 Days
    35.8836.9836.91

Peer Comparison

Found Peer Comparison useful?

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters30,09,48,72151.82 %0.00
    Pledge7,11,60,00023.65 %6.14
    FII8,84,96,70915.24 %1.28
    DII14,99,55,47325.82 %-1.83
    MF10,33,08,66817.79 %-1.73
    Others4,14,00,7207.12 %0.54
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters51.8251.8251.8251.82
    Pledge23.6517.5017.5017.08
    FII15.2413.9514.2014.38
    DII25.8227.6627.6026.93
    Mutual Funds17.7919.5219.3018.96
    Others7.126.576.376.87

Mutual Funds Ownership

MF Ownership as on 30 April 2026

View all Mutual Fund Schemes

Aurobindo Pharma Futures & Options

    DatePriceOpen Interest

    30-06-2026Current

    35.551.60 (4.71%)

    3,89,4005,500 (1.43%)

    30.00
    Open
    43.95
    High
    27.20
    Low
    33.95
    Close
    602
    Contracts Traded
    9,021.63
    Turnover (₹ Lakhs)

    Open Interest as of 10 Jun 2026

    • Expiry Month
    DatePriceOpen Interest

    30-06-2026Current

    1,459.500.90 (0.06%)

    1,74,28,4001,38,600 (0.80%)

    1,450.00
    Open
    1,475.00
    High
    1,445.20
    Low
    1,458.60
    Prev Close
    1,161
    Contracts Traded
    16,946.12
    Turnover (₹ Lakhs)

    Open Interest as of 10 Jun 2026

Aurobindo Pharma Top Searches

    Corporate Actions

    • Board Meeting

      Audited Results

      May 12, 2026

      General Meeting

      Buy Back of Shares

      Apr 06, 2026

      General Meeting

      Buy Back of Shares

      Apr 06, 2026

    • Announced onMeeting on
      May 12, 2026May 21, 2026
      Audited Results
      Apr 01, 2026Apr 06, 2026
      Buy Back of Shares
      Jan 30, 2026Feb 09, 2026
      Quarterly Results
      Oct 24, 2025Nov 05, 2025
      Quarterly Results
      Jul 23, 2025Aug 04, 2025
      Quarterly Results & Interim Dividend
    • Announced onEx-DateDividend%
      Aug 04, 2025Aug 08, 2025400%
      Feb 07, 2024Feb 20, 2024150%
      Nov 02, 2023Nov 20, 2023300%
      Feb 03, 2023Feb 17, 2023300%
      May 20, 2022Jun 06, 2022450%
    • Announced onEx-Date
      May 28, 2015Jul 20, 2015
      Bonus Ratio: 1 share(s) for every 1 shares held
      Feb 22, 2000Mar 07, 2000
      Bonus Ratio: 1 share(s) for every 1 shares held
      Oct 08, 1998Oct 26, 1998
      Bonus Ratio: 1 share(s) for every 1 shares held
    • Announced onEx-Date
      Nov 03, 2010Feb 10, 2011
      Split: Old FV5.0| New FV:1.0
      Aug 09, 2003Oct 23, 2003
      Split: Old FV10.0| New FV:5.0

    • No Data Available

    • Announced onMeeting on
      Apr 06, 2026-
      Buy Back of Shares
      Apr 06, 2026-
      Buy Back of Shares
      Apr 06, 2026-
      Buy Back of Shares
      Apr 06, 2026-
      Buy Back of Shares
      Apr 06, 2026-
      Buy Back of Shares

    About Aurobindo Pharma

    Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 84,425.32 Crore) operating in Pharmaceuticals sector.

    Show More

    Industry

    Pharma - Indian

    Key Indices Listed On

    Nifty Midcap 50, Nifty Midcap 100, Nifty 200, Nifty 500, BSE 500

    Address

    Plot No.2,Maitri Vihar,Ameerpet,Hyderabad, Telangana - 500038

    Contact

    info@aurobindo.com

    http://www.aurobindo.com

    Executive Leadership

    MR

    M Ramasubramanian Kumar

    Non Exe.Chairman&Ind.Director
    KN

    K Nithyananda Reddy

    Vice Chairman & Mng.Director
    MM

    M Madan Mohan Reddy

    Whole Time Director
    PS

    P Sarath Chandra Reddy

    Non Executive Director
    Show More

    Auditors

    Deloitte Haskins & Sells
    BSR & Associates LLP

    FAQs about Aurobindo Pharma share

    • 1. What's Aurobindo Pharma share price today and what are Aurobindo Pharma share returns ?
      As on 10 Jun, 2026, 03:50 PM IST Aurobindo Pharma share price is up by 0.32% basis the previous closing price of Rs 1,451.8. Aurobindo Pharma share price is Rs 1,453.60. Return Performance of Aurobindo Pharma Shares:
      • 1 Week: Aurobindo Pharma share price moved up by 0.92%
    • 2. What is the PE & PB ratio of Aurobindo Pharma?
      The PE ratio of Aurobindo Pharma stands at 22.55, while the PB ratio is 2.22.
    • 3. What are the returns for Aurobindo Pharma share?
      Return Performance of Aurobindo Pharma Shares:
      • 1 Week: Aurobindo Pharma share price moved up by 0.92%
    • 4. What is 52 week high/low of Aurobindo Pharma share price?
      52 Week high of Aurobindo Pharma share is Rs 1,550.00 while 52 week low is Rs 1,016.10
    • 5. What is the market cap of Aurobindo Pharma?
      Aurobindo Pharma share has a market capitalization of Rs 84,425.32 Cr. Within Pharmaceuticals sector, it's market cap rank is 9.

    Top Gainers

    As on 03:59 PM | 10 Jun 2026
    Inox India
    1,891.60
    204.90 (12.15%)
    Akums Drugs & Pharma
    592.10
    43.86 (8.00%)
    Chambal Fertilisers
    477.65
    22.90 (5.04%)
    Afcons Infrastru
    330.05
    14.56 (4.62%)
    Concord Biotech Ltd.
    1,330.70
    58.50 (4.60%)

    Top Losers

    As on 03:59 PM | 10 Jun 2026
    Oil India Ltd
    427.35
    -48.60 (-10.22%)
    IFCI
    71.83
    -5.24 (-6.80%)
    Manappuram Finance
    288.25
    -19.00 (-6.19%)
    Jindal Saw
    225.16
    -14.66 (-6.11%)
    NLC India
    309.60
    -18.15 (-5.54%)

    Equity Quick Links

    Top Gainers
    Top Losers
    Hourly gainers
    Hourly losers
    Sensex
    Nifty
    NSE
    BSE
    Midcap stocks
    Smallcap stocks
    Largecap stocks
    Sensex
    Nifty
    NSE
    BSE
    MCX Live

    More from Markets

    IPO
    Stock market news
    Budget 2022 Live Updates
    Cryptocurrency
    Currency converter
    NSE holiday list

    Trending in Markets

    DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

    DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this site, you agree to the Terms of Service and Privacy Policy.

    Business News › Markets › Stocks › Stock Price Quotes › Aurobindo Pharma Share Price

    Browse Companies

    ABCDEFGHIJKLMNOPQRSTUVWXYZ
    123456789

    Popular Categories

    Hot on Web

    In Case you missed it

    Top Searched Companies

    Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
    Times Syndication Service

    Do Not Sell My Personal Information